Incidence of ifosfamide-induced neurotoxicity in lymphoma patients receiving fractionated ICE-based chemotherapy.

@article{Chow2004IncidenceOI,
  title={Incidence of ifosfamide-induced neurotoxicity in lymphoma patients receiving fractionated ICE-based chemotherapy.},
  author={H Chow and Crystal Lim and Wai Ong and Heng Joo Ng},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2004},
  volume={22 14_suppl},
  pages={6677}
}
6677 Background: Ifosfamide-induced neurotoxicity is a treatment-related complication that is increasingly being reported. Here, we describe the incidence and presentation of neurotoxicity in our patients. METHODS We reviewed all Hodgkin's and Non-Hodgkin's lymphoma patients who received fractionated ICE (D1-3: ifosfamide 2g/m2 over 2h with an equivalent… CONTINUE READING